Search Tag: Brahms PCT

ICU Management

How to overcome antibiotic overuse in COVID-19 patients?

2021 24 Mar

Find Thermo Fisher Scientific on Social Media   Read more

Executive Health Management

Ortho’s Next Gen TSH3 Assay to Assess Thyroid and/or Pituitary Disorders Achieves CE Mark

2020 13 Nov

Ortho Clinical Diagnostics , a global leader of in vitro diagnostics, today announced its VITROS® Immunodiagnostic Products TSH3 (Thyroid Stimulating Hormone) Reagent Pack and Calibrator has achieved CE Mark and will be commercially available in the beginning of December* to aid clinicians in assessing and diagnosing thyroid and/or pituitary gland... Read more

ICU Management

PCT-guided Antibiotic Stewardship in COVID-19 Patients

2020 14 Sep

Professor Michael Mansour is a physician-scientist with a research concentration in immune responses against invading pathogens. He attends on the Clinical Transplant Infectious Diseases and Immunocompromised Host Service at the Massachusetts General Hospital - Division of Infectious Diseases, where he cares for solid and stem cell transplant recipients... Read more

Health Management

The Role of Procalcitonin for Risk Assessment and Treatment of COVID-19 Patients

2020 03 Aug

Procalcitonin is widely used to assess the risk of bacterial infection and disease progression. Can it be an additional tool to identify COVID-19 patients at risk of severe disease? Key Points Procalcitonin (PCT) is a widely used biomarker to assess the risk of bacterial infection and disease progression. Early evidence... Read more

Health Management

B·R·A·H·M·S PCT: A Valuable Tool for Bacterial Coinfection Risk Assessment

2020 23 Jun

Procalcitonin – A Critical Biomarker Procalcitonin (PCT) is a member of the calcitonin family and known as a critical biomarker for bacterial infections. To be effective a biomarker must have high diagnostic accuracy and allow early and rapid diagnosis. PCT fulfills these requirements and has already demonstrated superior diagnostic accuracy compared... Read more

ICU Management

FDA Clears Test to Help Manage Antibiotic Treatment For Lower Respiratory Tract Infections & Sepsis

2017 22 Mar

The U.S. Food and Drug Administration today cleared the expanded use of the Vidas Brahms PCT Assay to help health care providers determine if antibiotic treatment should be started or stopped in patients with lower respiratory tract infections, such as community-acquired pneumonia, and stopped in patients with sepsis. This is the first test to use... Read more